AKT1 and central nervous system cancer: Functional studies have demonstrated that DDX11-AS1 interacts with RNA-binding protein heterogeneous nuclear ribonucleoprotein C (HNRNPC), promoting Wnt/β-catenin and AKT pathways, as well as epithelial-mesenchymal transition, thereby facilitating glioma cell proliferation [35].